Sign In
Buy BAYRY
$9.92
+0.0400 (+0.405%)
At Close: Jun 03, 2026
The Cancer Victims Who Could Sink Bayer's Roundup Settlement
11:45am, Monday, 20'th Apr 2026
With thousands of cases piling up in U.S. courts, the company's relief plans still face hurdles.
US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims
10:36pm, Friday, 17'th Apr 2026
A U.S. judge has rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that its multibillion-dollar drug cuts the risk of death from prostate cancer in h
U.S. judge rejects Bayer's bid to block Johnson & Johnson prostate cancer drug claims
07:00pm, Friday, 17'th Apr 2026
A federal judge rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that its multibillion-dollar drug cuts the risk of death from prosta
Bayer Canada Supports New School of Medicine at Simon Fraser University (SFU) With Full Tuition Entrance Award for Inaugural Class
04:33pm, Wednesday, 15'th Apr 2026
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Bayer Canada is proud to support the Simon Fraser University (SFU) School of Medicine - the first medical school in Western Canada in nearly 60 years. The new sc
Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Sees Significant Growth in Short Interest
04:09am, Monday, 13'th Apr 2026
Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 216,042 s
Bayer US head says tariffs will not affect its 2026 forecasts
01:38pm, Tuesday, 07'th Apr 2026
A top Bayer AG executive said on Tuesday the German drugmaking and crop science company saw no need to adjust its 2026 forecasts because of tariffs on imported pharmaceuticals announced by the U
Bayer Advances AB-1002 Study, Highlights Pharma Growth Strategy
03:30pm, Thursday, 02'nd Apr 2026
Bayer advances AB-1002 after AskBio completes mid-stage study enrollment, as its Pharma strategy and pipeline milestones drive long-term growth outlook.
Bayer Wins EC Approval to Expand Kerendia in Heart Failure Treatment
02:46pm, Tuesday, 31'st Mar 2026
Bayer wins EU nod to expand Kerendia's use in heart failure, backed by strong phase III data, boosting a key drug driving growth and portfolio momentum.
Following a challenge brought by OLLY PBC, BBB National Programs' National Advertising Division recommended that Bayer HealthCare LLC discontinue or modify certain claims for its One A Day® Men's Pre
BERLIN--(BUSINESS WIRE)--Bayer today announced a leadership change within its Pharmaceuticals' Worldwide Markets organization to accelerate the strong performance and growth of its key pharmaceutical
Bayer: Turnaround Is Underway - Don't Miss It
11:30am, Thursday, 26'th Mar 2026
Bayer remains a 'Buy' as litigation overhangs ease and intrinsic value points to deep undervaluation. Despite disappointing 2025 results, Bayer's core business shows resilience, with litigation settle
Bayer Crop Science Canada Redefines Canola Innovation With New "Advancing Better Canola" Initiative
11:30am, Thursday, 26'th Mar 2026
CALGARY, Alberta--(BUSINESS WIRE)--Bayer Crop Science Canada launches Advancing Better Canola (ABCs), an industry-wide initiative to challenge and redefine how it thinks about canola innovation in sup
Short Interest in Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Grows By 178.9%
02:56am, Wednesday, 25'th Mar 2026
Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) was the target of a significant increase in short interest in March. As of March 13th, there was short interest totaling 123,788 shares, an i
BAYRY Reports Positive Data on Kidney Drug in Non-Diabetic CKD
02:06pm, Tuesday, 17'th Mar 2026
Bayer's finerenone hits key phase III goal in non-diabetic CKD, paving the way to expand Kerendia???s use as data strengthens its cardiorenal therapy role.
Bayer Crop Science Launches 2026 Opportunity Scholarship Program
11:00am, Monday, 16'th Mar 2026
CALGARY, Alberta--(BUSINESS WIRE)--Bayer Crop Science Canada is excited to support the future of Canadian agriculture with its 2026 Bayer Crop Science Opportunity Scholarship. Through the scholarship,
